In this issue:
Stem-cell therapy for complex perianal fistulae in CD
Outcomes after abdominal CD surgery under ustekinumab treatment
Outcomes after abdominal IBD surgery under vedolizumab treatment
Ileocaecal anastomosis type and long-term clinical status in postoperative CD
Vedolizumab and anti-TNF co-exposure in IBD
Faecal calprotectin excludes IBD with or without alarm symptoms
Bases for increasing infliximab doses in active luminal CD
Indigo naturalis (Chinese medicine) in UC
Telemonitoring for paediatric IBD
Anti-TNF re-induction vs. dose interval shortening after loss of response
Please login below to download this issue (PDF)